Overview
Discusses the progress in linking the biology of ovarian cancer with novel targets and innovative therapies entering clinical trials.
Provides an up-to-date perspective on successful therapeutic developments as a partnership between laboratory-based and clinical-based research scientists.
Identifies those areas of translational research which we believe have shown the most promise, or are likely to do so, in the treatment of ovarian cancer.
Includes supplementary material: sn.pub/extras
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (13 chapters)
About this book
Editors and Affiliations
Bibliographic Information
Book Title: Emerging Therapeutic Targets in Ovarian Cancer
Editors: Stan Kaye, Robert Brown, Hani Gabra, Martin Gore
DOI: https://doi.org/10.1007/978-1-4419-7216-3
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media, LLC 2011
Hardcover ISBN: 978-1-4419-7215-6Published: 24 November 2010
Softcover ISBN: 978-1-4899-8233-9Published: 27 November 2014
eBook ISBN: 978-1-4419-7216-3Published: 23 November 2010
Edition Number: 1
Number of Pages: XIII, 291
Topics: Cancer Research, Pharmacology/Toxicology